CXCL8 and colonic neoplasm: SB225002, an antagonist of CXCR2, reduced Tyr705 phosphorylation of STAT3 and IL‐8 protein expression in HCT116 colon cancer cells, which was also apparent in HCT116 sh‐ZNF143 cells.